News by Tag: Amylin
Amylin Pharmaceutical found to hold back Byetta's safety data
June 29, 2012
FDA still claims that Amylin has mislead the regulatory body by proving incomplete information with regard to the heart effects of its diabetes drug called Byetta or Bydureon, which has been approved in January for use in diabetic patients.
June 29, 2012
FDA still claims that Amylin has mislead the regulatory body by proving incomplete information with regard to the heart effects of its diabetes drug called Byetta or Bydureon, which has been approved in January for use in diabetic patients.